Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

Nature Biotechnology volume 16, pages 364–369 (1998)Cite this article

Abstract

Dendritic cells (DC) generated from the peripheral blood mononuclear cells of healthy individuals or from cancer patients transfected with carcinoembryonic antigen (CEA) mRNA stimulate a potent CD8+ cytotoxic T lymphocyte (CTL) response in vitro. DCs are effectively sensitized with RNA in the absence of reagents commonly used to facilitate mammalian cell transfection. RNA encoding a chimeric CEA/LAMP-1 lysosomal targeting signal enhances the induction of CEA-specific CD4+ T cells, providing a strategy to induce T-help that may be necessary to generate and/or maintain an optimal CD8+ CTL response in vivo. CEA RNA-transfected DCs also serve as effective targets in cytotoxicity assays, thus providing a general method for inducing, as well as measuring, CEA-specific CTL responses across a broad spectrum of HLA haplotypes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Steinman, R.M. The dendtitic cell system and its role in immunogenicity.Ann. Rev. Immunol. 9: 271–296.

    Article  CAS  PubMed  Google Scholar 

  2. Nair, S., Zhou, F., Reddy, R., Huang, L., and Rouse, B.T. 1992. Solubel proteins delivered to dendritic cells via pH–sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175: 609–612.

    Article  CAS  PubMed  Google Scholar 

  3. Nair, S. Babu, J.S., Dunham, R.G. Kanda, P., Burke, R.L., and Rouse, B.T. 1993. Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. J. Virol. 67: 4062–4069.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Rouse, R.J.D. Nair, S.K., Lydy, S.L. Bowen, J.C., and Rouse, B.T. 1994. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. J. Virol. 68: 5685–5689.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Porgador, A. and Gilboa, E. 1995. Bone marrow generated dendritic cells pulsed with a class l-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182: 255–260.

    Article  CAS  PubMed  Google Scholar 

  6. Takahashi, H. Nakagawa, Y., Yokomuro, K., and Berzofsky, J. A. 1993. Induction of CDS+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed cells. Int. Immunol. 5: 849–857.

    Article  CAS  PubMed  Google Scholar 

  7. Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., DeLeo, A.B., Clarke, M.R., Lotze, M.T., and Storkus, W.J. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183: 87–97.

    Article  CAS  PubMed  Google Scholar 

  8. Paglia, P., Chiodoni, C., Rodolfo, M., and Colombo, M.P. 1996. Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo. J. Exp. Med. 183: 317–322.

    Article  CAS  PubMed  Google Scholar 

  9. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, H., Bazin, F. et al. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. of Immunol. 24: 605–610.

    Article  CAS  Google Scholar 

  10. Porgador, A., Snyder, D., and Gilboa, E. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immumol. 156: 2918–2926.

    CAS  Google Scholar 

  11. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D. et al. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat. Med. 1: 1297–1302.

    Article  CAS  PubMed  Google Scholar 

  12. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B. et al. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2: 52–58.

    Article  CAS  PubMed  Google Scholar 

  13. Ossevoort, M.A., Feltkamp, M.C.W., van Veen, K.J.H., Melief, C.J.M., and Kast, W.M. 1995. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor. J. Immunotherapy 18: 86–94.

    Article  CAS  Google Scholar 

  14. Nair, S.K., Snyder, D., Rouse, B.T., and Gilboa, E. 1997. Regression of tumors in mice vaccinated with professional antigen presenting cells pulsed with tumor extracts. Int. J. Cancer 70: 706–715.

    Article  CAS  PubMed  Google Scholar 

  15. Boczkowski, D., Nair, S., Snyder, D., and Gilboa, E. 1996. Dendritic cells pulsed with RNA are potent antigen presenting cells in vitro and in vivo. J. Exp. Med. 184: 465–472.

    Article  CAS  PubMed  Google Scholar 

  16. Tsang, K.Y., Zaremba, S., Nieroda, C.A., and Schlom, J. 1995. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. Natl. Cancer Inst. 87: 982–989.

    Article  CAS  PubMed  Google Scholar 

  17. Celis, E.V., Tsai, S., Crimi, C., DeMars, R., Wentworth, P.A., Chestnut, R.W. et al. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91: 2105–2109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gagliardi, M.C., Petrillo, G.D., Salemi, S., Boffa, L., Longobardi, M.G., Dellabona, P. et al. 1995. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol. 7: 1741–1752.

    Article  CAS  PubMed  Google Scholar 

  19. Macatonia, S.E., Patterson, S., and Knight, S.C. 1991. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology 74: 399–406.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Mehta-Damani, A., Markowicz, S., and Engleman, E.G. 1994. Generation of antigen-specific CD8+ CTLs from naive precursors. J. Immunol 153: 996–1003.

    CAS  PubMed  Google Scholar 

  21. Bakker, A.B.H., Marland, G., de Boer, A.J., Huijbens, R.J.F., Danen, E.H.J., Adema, G.J., and Figdor, C.G. 1995. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 55: 5330–5334.

    CAS  PubMed  Google Scholar 

  22. Reeves, M., Royal, R.E., Lam, J.S., Rosenberg, S.A and Hwu, P. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 56: 5672–5677.

    CAS  PubMed  Google Scholar 

  23. Wong, C.W., Morse, M. and Nair, S.K. 1998. Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides. J. Immunotherapy 21: 32–40.

    Article  CAS  Google Scholar 

  24. Stern, P.L. 1996. Immunity to human papillomavirus-associated cervical neoplasia. Adv. Cancer Res 69: 175–211.

    Article  CAS  PubMed  Google Scholar 

  25. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., and Prasher, D.C. 1994. Green fluorescent protein as a marker for gene expression. Science 263: 802–805.

    Article  CAS  PubMed  Google Scholar 

  26. Felgner, J., Bennett, F., and Felgner, P.L. 1993. Cationic lipid-mediated delivery of poiynucleotides. Methods 5: 67–75.

    Article  CAS  Google Scholar 

  27. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med 182: 389–400.

    Article  CAS  PubMed  Google Scholar 

  28. Lanzavecchia, A. 1996. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8: 348–354.

    Article  CAS  PubMed  Google Scholar 

  29. Morse, M.A., Zhou, L.-J., Tedder, T.F., Lyerly, K. and Smith, C. 1997. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with GM-CSF, IL-4, and TNFα for use in cancer immunotherapy. Ann. Surgery 226: 6–16.

    Article  CAS  Google Scholar 

  30. Keene, J. and Forman, J. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med 155: 768–782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. von Herrath, M.G., Yokoyama, M., Dockter, J., Oldstone, M.B.A., and Whitton, J.L. 1996. CD4-Deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol 70: 1072–1079.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Bennett, S.R.M., Carbone, F.R., Karamalis, F., Miller, J.F.A.P., and Heath, W.R. 1997. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med. 186: 65–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Rock, K.L. and K, Clark 1996. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J. Immunol 156: 3721–3726.

    CAS  PubMed  Google Scholar 

  34. Wu, T.-C., Guarnier, F.G., Staveley-O'Carroll, K.F., Viscidi, R.P., Levitsky, H.I., Hedrick, K.R. et al. 1995. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc. Natl. Acad. Sci. USA 92: 11671–11675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lin, K.-Y., Guarnier, F.G., Staveley-O'Carroll, K.F., Viscidi, R.P., Levitsky, H.I., Hedrick, K.R. et al. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56: 21–26.

    CAS  PubMed  Google Scholar 

  36. Babu, J.S., Nair, S., Kanda, P., and Rouse, B.T. 1995. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. Vaccine 13: 1669–1676.

    Article  CAS  PubMed  Google Scholar 

  37. Siliciano, R.F., Lawton, T., Knall, C., Karr, R.W., Berman, P., Gregory, T. et al. 1988. Analysis of host-virus interactions in AIDS with human T cell clones specific for HIV gp120: effect of HIV genomic heterogeneity and a mechanism for CD4+ cell depletion. Cell 54: 561–575.

    Article  CAS  PubMed  Google Scholar 

  38. Kern, D.E., Klarnet, J.P., Jensen, M.C.V., and Greenberg, P.D. 1986. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I restricted CTL. J. Immunol. 136: 4303–4315.

    CAS  PubMed  Google Scholar 

  39. Lechler, R., Aichinger, G., and Lightstone, L. 1996. The endogenous pathway of MHC class II antigen presentation. Immunol. Rev. 151: 51–79.

    Article  CAS  PubMed  Google Scholar 

  40. Salter, R.D., Howell, D.N., and Cresswell, P. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235–246.

    Article  CAS  PubMed  Google Scholar 

  41. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B. et al. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83–93.

    Article  CAS  PubMed  Google Scholar 

  42. Volgmann, T., Klein-Struckmeier, A., and Mohr, H. 1989. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. J. Immunol. Methods 119: 45–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Genetic and Cellular Therapies, Department of Surgery, Duke University Medical Center, Durham, NC, 27710

    Smita K. Nair, David Boczkowski, Michael Morse, R. Ian Cumming, H. Kim Lyerly & Eli Gilboa

Authors
  1. Smita K. Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Boczkowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Morse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Ian Cumming
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Kim Lyerly
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eli Gilboa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eli Gilboa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nair, S., Boczkowski, D., Morse, M. et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 16, 364–369 (1998). https://doi.org/10.1038/nbt0498-364

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0498-364

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing